Loading...

Multi Indocitra

DB:QF9
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
QF9
DB
IDR223B
Market Cap
  1. Home
  2. DE
  3. Retail
Company description

PT Multi Indocitra Tbk produces and trades in baby and health care products, and cosmetics in Indonesia. The last earnings update was 54 days ago. More info.


Add to Portfolio Compare Print
  • Multi Indocitra has significant price volatility in the past 3 months.
QF9 Share Price and Events
7 Day Returns
-10%
DB:QF9
0.3%
Europe Retail Distributors
1.6%
DE Market
1 Year Returns
2%
DB:QF9
-11.1%
Europe Retail Distributors
-7.4%
DE Market
QF9 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Multi Indocitra (QF9) -10% -15% -19.5% 2% -38.8% -10%
Europe Retail Distributors 0.3% 2.9% 6.6% -11.1% -5.9% 1.9%
DE Market 1.6% 1.9% 2.6% -7.4% 14.7% 9.4%
1 Year Return vs Industry and Market
  • QF9 outperformed the Retail Distributors industry which returned -11.1% over the past year.
  • QF9 outperformed the Market in Germany which returned -7.4% over the past year.
Price Volatility
QF9
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Multi Indocitra's competitors could be found in our database.

Value

 Is Multi Indocitra undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Multi Indocitra. This is due to cash flow or dividend data being unavailable. The share price is €0.0153.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Multi Indocitra's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Multi Indocitra's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:QF9 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in IDR IDR54.52
IDX:MICE Share Price ** IDX (2019-06-21) in IDR IDR374
Europe Retail Distributors Industry PE Ratio Median Figure of 22 Publicly-Listed Retail Distributors Companies 12.24x
Germany Market PE Ratio Median Figure of 425 Publicly-Listed Companies 19.87x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Multi Indocitra.

DB:QF9 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= IDX:MICE Share Price ÷ EPS (both in IDR)

= 374 ÷ 54.52

6.86x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Multi Indocitra is good value based on earnings compared to the Europe Retail Distributors industry average.
  • Multi Indocitra is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Multi Indocitra's expected growth come at a high price?
Raw Data
DB:QF9 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 6.86x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
21.7%per year
Europe Retail Distributors Industry PEG Ratio Median Figure of 7 Publicly-Listed Retail Distributors Companies 1.11x
Germany Market PEG Ratio Median Figure of 271 Publicly-Listed Companies 1.46x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Multi Indocitra, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Multi Indocitra's assets?
Raw Data
DB:QF9 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in IDR IDR1,080.81
IDX:MICE Share Price * IDX (2019-06-21) in IDR IDR374
Europe Retail Distributors Industry PB Ratio Median Figure of 25 Publicly-Listed Retail Distributors Companies 1.66x
Germany Market PB Ratio Median Figure of 575 Publicly-Listed Companies 1.8x
DB:QF9 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= IDX:MICE Share Price ÷ Book Value per Share (both in IDR)

= 374 ÷ 1,080.81

0.35x

* Primary Listing of Multi Indocitra.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Multi Indocitra is good value based on assets compared to the Europe Retail Distributors industry average.
X
Value checks
We assess Multi Indocitra's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Retail Distributors industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Retail Distributors industry average (and greater than 0)? (1 check)
  5. Multi Indocitra has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Multi Indocitra expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Multi Indocitra, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Multi Indocitra expected to grow at an attractive rate?
  • Multi Indocitra's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Multi Indocitra's earnings growth is expected to exceed the Germany market average.
  • Unable to compare Multi Indocitra's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:QF9 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:QF9 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 21.7%
Europe Retail Distributors Industry Earnings Growth Rate Market Cap Weighted Average 18.2%
Europe Retail Distributors Industry Revenue Growth Rate Market Cap Weighted Average 1.7%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.5%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:QF9 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in IDR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:QF9 Past Financials Data
Date (Data in IDR Millions) Revenue Cash Flow Net Income *
2019-03-31 669,699 -40,919 32,464
2018-12-31 637,905 -41,564 32,998
2018-09-30 622,312 -17,704 34,197
2018-06-30 602,843 -23,832 70,978
2018-03-31 590,522 18,948 68,167
2017-12-31 570,153 5,049 66,627
2017-09-30 481,133 13,392 59,798
2017-06-30 498,256 46,205 14,344
2017-03-31 527,559 4,655 15,871
2016-12-31 552,344 24,912 20,749
2016-09-30 635,378 26,966 30,461
2016-06-30 613,143 -11,664 25,049

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Multi Indocitra's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if Multi Indocitra is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:QF9 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Multi Indocitra Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:QF9 Past Financials Data
Date (Data in IDR Millions) EPS *
2019-03-31 54.52
2018-12-31 55.42
2018-09-30 57.43
2018-06-30 119.21
2018-03-31 114.49
2017-12-31 111.90
2017-09-30 100.44
2017-06-30 24.12
2017-03-31 26.67
2016-12-31 34.85
2016-09-30 51.13
2016-06-30 41.98

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Multi Indocitra will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Multi Indocitra's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Multi Indocitra has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Multi Indocitra performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Multi Indocitra's growth in the last year to its industry (Retail Distributors).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Multi Indocitra's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • Multi Indocitra's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Multi Indocitra's 1-year earnings growth is negative, it can't be compared to the Europe Retail Distributors industry average.
Earnings and Revenue History
Multi Indocitra's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Multi Indocitra Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:QF9 Past Revenue, Cash Flow and Net Income Data
Date (Data in IDR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 669,699.31 32,464.39 325,836.29
2018-12-31 637,904.73 32,998.41 307,456.44
2018-09-30 622,311.70 34,196.86 302,470.65
2018-06-30 602,842.55 70,978.39 298,190.31
2018-03-31 590,522.03 68,167.03 293,613.02
2017-12-31 570,153.32 66,627.07 285,465.43
2017-09-30 481,133.40 59,798.29 270,939.92
2017-06-30 498,256.07 14,344.03 268,965.90
2017-03-31 527,558.57 15,871.07 279,689.54
2016-12-31 552,343.83 20,749.02 279,242.09
2016-09-30 635,377.88 30,461.18 286,293.72
2016-06-30 613,142.70 25,049.29 286,672.63
2016-03-31 584,789.55 24,325.53 270,424.88
2015-12-31 555,215.58 23,344.38 259,051.04
2015-09-30 548,271.02 27,063.65 254,751.01
2015-06-30 547,637.86 38,114.31 245,742.35
2015-03-31 541,664.44 36,147.60 243,541.95
2014-12-31 528,357.95 37,811.81 240,023.64
2014-09-30 553,911.52 39,208.38 243,974.35
2014-06-30 551,277.36 35,497.17 239,157.63
2014-03-31 579,051.69 41,434.36 236,266.45
2013-12-31 591,342.58 40,044.21 234,613.36
2013-09-30 581,427.06 34,433.20 239,924.35
2013-06-30 574,808.68 39,394.89 230,956.36
2013-03-31 559,821.54 40,927.12 227,060.68
2012-12-31 560,033.42 40,655.58 230,076.45
2012-09-30 525,640.88 35,161.67 241,553.06
2012-06-30 505,341.83 31,578.98 229,985.96

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Multi Indocitra has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Multi Indocitra used its assets more efficiently than the Europe Retail Distributors industry average last year based on Return on Assets.
  • Multi Indocitra's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Multi Indocitra's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Retail Distributors industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Multi Indocitra has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Multi Indocitra's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Multi Indocitra's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Multi Indocitra is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Multi Indocitra's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Multi Indocitra's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Multi Indocitra Company Filings, last reported 2 months ago.

DB:QF9 Past Debt and Equity Data
Date (Data in IDR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 633,595.49 225,690.00 46,637.87
2018-12-31 637,712.00 213,296.69 53,377.59
2018-09-30 624,400.54 155,841.72 61,070.20
2018-06-30 613,400.54 148,023.29 55,179.97
2018-03-31 614,475.30 83,084.61 85,993.34
2017-12-31 607,382.21 139,171.81 135,680.87
2017-09-30 596,878.03 162,916.82 31,942.67
2017-06-30 596,882.95 139,826.56 64,118.96
2017-03-31 596,415.65 145,286.74 61,101.85
2016-12-31 600,813.35 157,411.34 49,263.66
2016-09-30 602,786.05 139,506.66 86,517.22
2016-06-30 597,293.36 125,058.27 62,251.47
2016-03-31 594,388.51 109,885.54 88,280.91
2015-12-31 583,972.26 117,081.20 85,203.29
2015-09-30 535,616.04 96,948.65 50,103.46
2015-06-30 540,288.48 82,009.52 52,099.64
2015-03-31 540,524.36 56,593.61 35,733.21
2014-12-31 528,616.30 64,638.26 71,314.73
2014-09-30 518,955.12 58,274.03 42,152.04
2014-06-30 508,179.56 60,163.88 39,668.53
2014-03-31 505,505.01 55,252.80 42,408.18
2013-12-31 495,402.44 58,072.85 49,865.14
2013-09-30 366,278.48 55,617.65 45,789.43
2013-06-30 359,312.34 51,143.75 30,253.76
2013-03-31 349,659.72 54,303.75 44,236.41
2012-12-31 339,170.98 50,635.91 51,012.81
2012-09-30 327,302.35 55,314.93 43,468.47
2012-06-30 326,753.70 76,007.36 35,155.25
  • Multi Indocitra's level of debt (35.6%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (10.9% vs 35.6% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 3.2x coverage).
X
Financial health checks
We assess Multi Indocitra's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Multi Indocitra has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Multi Indocitra's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.67%
Current annual income from Multi Indocitra dividends.
If you bought €2,000 of Multi Indocitra shares you are expected to receive €53 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Multi Indocitra's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.45%).
  • Multi Indocitra's dividend is below the markets top 25% of dividend payers in Germany (3.83%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:QF9 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Retail Distributors Industry Average Dividend Yield Market Cap Weighted Average of 14 Stocks 3.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:QF9 Past Annualized Dividends Data
Date (Data in IDR) Dividend per share (annual) Avg. Yield (%)
2019-03-29 10.000 2.397
2018-04-02 10.000 2.602
2017-05-18 10.000 2.669
2016-11-01 0.000 0.000
2016-08-01 0.000 0.000
2016-04-29 0.000 0.000
2016-03-31 0.000 0.000
2015-07-31 10.000 2.904
2015-03-30 10.000 3.112
2014-03-28 15.000 4.012
2013-10-29 15.000 3.675
2013-03-27 15.000 3.088
2012-10-31 20.000 4.788
2012-03-30 20.000 5.102
2011-10-31 24.000 6.397
2011-05-20 24.000 5.741
2010-10-29 20.000 5.318
2010-04-30 20.000 5.335
2009-10-28 20.000 7.568
2009-08-03 20.000 7.165

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of Multi Indocitra's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (5.5x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Multi Indocitra's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Multi Indocitra afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Multi Indocitra has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Multi Indocitra's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Anthony Honoris
AGE 35
TENURE AS CEO 4.1 years
CEO Bio

Mr. Anthony Honoris has been a Director of PT Multi Indocitra Tbk since may 2013. Mr. Honoris graduated from melbourne university of business management in 2005.

CEO Compensation
  • Insufficient data for Anthony to compare compensation growth.
  • Insufficient data for Anthony to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team

Anthony Honoris

TITLE
President Director
AGE
35
TENURE
4.1 yrs

Ali Arifin

TITLE
Company Secretary
AGE
34
Board of Directors Tenure

Average tenure and age of the Multi Indocitra board of directors in years:

6.9
Average Tenure
49
Average Age
  • The tenure for the Multi Indocitra board of directors is about average.
Board of Directors

Anthony Honoris

TITLE
President Director
AGE
35
TENURE
4.1 yrs

Alka Tranggana

TITLE
President Commissioner
AGE
56
TENURE
7.1 yrs

H. Syafei

TITLE
Independent Commissioner
AGE
75
TENURE
11.1 yrs

Budiman Gitaloka

TITLE
Independent Director
AGE
42
TENURE
6.7 yrs

Hendro Wibowo

TITLE
Independent Director
AGE
41
TENURE
4.8 yrs

Budi Setyawan

TITLE
Commissioner
AGE
68
TENURE
7.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Multi Indocitra's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Multi Indocitra has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

PT Multi Indocitra Tbk produces and trades in baby and health care products, and cosmetics in Indonesia. The company offers bottle teats, pacifiers, breast pumps, baby toiletries, diapers, wet wipes, and toys, as well as a range of products for senior citizens under the Pigeon brand name. It also provides kitchen and houseware items, such as plastic airtight containers under the Lock&Lock brand name. In addition, the company is involved in the retail sale of baby products. PT Multi Indocitra Tbk offers its products through third party suppliers and sub-distributors. The company was founded in 1990 and is based in West Jakarta, Indonesia.

Details
Name: PT Multi Indocitra Tbk
QF9
Exchange: DB
Founded: 1990
IDR13,903,451
595,423,000
Website: http://www.mic.co.id
Address: PT Multi Indocitra Tbk
Green Central City,
6th Floor,
West Jakarta,
Jakarta Raya, 11120,
Indonesia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
IDX MICE Common Stock Indonesia Stock Exchange ID IDR 21. Dec 2005
DB QF9 Common Stock Deutsche Boerse AG DE EUR 21. Dec 2005
Number of employees
Current staff
Staff numbers
463
Multi Indocitra employees.
Industry
Distributors
Retail
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/23 21:00
End of day share price update: 2019/06/21 00:00
Last earnings filing: 2019/04/30
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.